Category

ECM

Daily Brief ECM: MR. D.I.Y. Thailand Pre-IPO – Largest Home Improvement Retailer in Thailand and more

By | Daily Briefs, ECM

In today’s briefing:

  • MR. D.I.Y. Thailand Pre-IPO – Largest Home Improvement Retailer in Thailand
  • Smartworks Coworking Spaces Pre-IPO – Healthy Revenue Growth Led by Strategic Capacity Expansion
  • Rigaku IPO – The Negatives – Not Every Segment Has Been Performing; Has a Large Overhang as Well
  • Oswal Pumps Pre-IPO Tearsheet


MR. D.I.Y. Thailand Pre-IPO – Largest Home Improvement Retailer in Thailand

By Nicholas Tan

  • Mr. DIY Holding (Thailand) (2472516D TB)  is looking to raise as much as US$300m in its upcoming IPO in Thailand.
  • It is the largest home improvement retailer in Thailand offering value prices i.e. “Always Low Prices” for over 15,000 products across a variety of departments. 
  • In this note, we look at the firm’s past performance.

Smartworks Coworking Spaces Pre-IPO – Healthy Revenue Growth Led by Strategic Capacity Expansion

By Akshat Shah

  • Smartworks Coworking Spaces Ltd (1742134D IN) is looking to raise about US$120m in its India IPO.
  • It is an office experience and managed campus platform, typically focused on leasing entire/large, bare shell properties in prime locations and transforming them into fully serviced, tech-enabled campuses with amenities.
  • In this note, we talk about the company’s historical performance.

Rigaku IPO – The Negatives – Not Every Segment Has Been Performing; Has a Large Overhang as Well

By Clarence Chu

  • Rigaku Holdings (268A JP) is looking to raise US$762m in its Japan IPO.
  • Rigaku engages in developing, manufacturing, sales and servicing scientific instruments specializing in X-ray technologies.
  • In this note, we will talk about the not so positive aspects of the deal.

Oswal Pumps Pre-IPO Tearsheet

By Nicholas Tan

  • Oswal Pumps Limited is looking to raise about US$122m in its upcoming Indian IPO. The deal will be run by IIFL Securities, Axis Capital, CLSA, JMF and Nuvama Wealth Management.
  • Oswal Pumps is the fastest growing vertically integrated solar pump manufacturer in India.
  • The firm manufactures solar-powered and grid-connected submersible and monoblock pumps, electric motors comprising induction and submersible motors as well as solar modules, sold under the ‘Oswal’ brand.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Tokyo Metro (9023 JP) IPO: The Bear Case and more

By | Daily Briefs, ECM

In today’s briefing:

  • Tokyo Metro (9023 JP) IPO: The Bear Case
  • Rigaku Holdings IPO: Initial Thoughts
  • Rigaku IPO – The Positives – Catering to a Range of End Industries, and Track Record Has Been Strong
  • Japan Metropolitan Fund Placement – Relatively Small Deal to Digest
  • Tokyo Metro IPO – The Negatives – Hasn’t Recovered Fully but Div and Debt Have
  • Pre-IPO Eternal Beauty Holdings – The Perfume Business in China May Not Be as Good as Expected


Tokyo Metro (9023 JP) IPO: The Bear Case

By Arun George

  • Tokyo Metro (9023 JP), a mass transit operator, is seeking to raise up to US$2.3 billion. Pricing is on 15 October, and the listing is on 23 October.
  • In Tokyo Metro (9023 JP) IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on mid-tier revenue growth, low revenue diversification, the highest leverage among peers and a sizeable post-IPO share overhang. 

Rigaku Holdings IPO: Initial Thoughts

By Shifara Samsudeen, ACMA, CGMA

  • Rigaku Holdings (268A JP) provides cutting-edge analytical solutions centered on X-ray technology globally. The company is one of the largest players globally in X-ray diffraction instrument market.
  • The company has filed for an IPO on the Tokyo Stock Exchange and plans to raise proceeds of around US$900m from the IPO at a potential valuation of US$2bn.
  • In this insight, we discuss Rigaku’s business model, key drivers, financials and outlook for the company.

Rigaku IPO – The Positives – Catering to a Range of End Industries, and Track Record Has Been Strong

By Clarence Chu

  • Rigaku Holdings (268A JP) is looking to raise US$762m in its Japan IPO.
  • Rigaku engages in developing, manufacturing, sales and servicing scientific instruments specializing in X-ray technologies. 
  • In this note, we will talk about the positive aspects of the deal.

Japan Metropolitan Fund Placement – Relatively Small Deal to Digest

By Sumeet Singh

  • Japan Metropolitan Fund Investment Corporation (8953 JP) aims to raise around US$140m to partly fund the acquisition of four assets.
  • The deal will be relatively small, in terms of ADV and dilution.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Tokyo Metro IPO – The Negatives – Hasn’t Recovered Fully but Div and Debt Have

By Sumeet Singh

  • Tokyo Metro (9023 JP)‘s shareholders aim to raise up to US$2.3bn in its Japan IPO.
  • Tokyo Metro (TKM) is one of the two metro network operators in the Tokyo region. It operates nine subway lines with a total of 180 stations.
  • In this note, we talk about the not-so-positive aspects of the deal.

Pre-IPO Eternal Beauty Holdings – The Perfume Business in China May Not Be as Good as Expected

By Xinyao (Criss) Wang

  • The essence of Eternal Beauty’s business model is to earn a “price difference” of the brand and product portfolios, but this business model is difficult to generate high profit margins.
  • The situation and prospects of China’s perfume market are facing major changes. It‘s uncertain whether the perfume sales in the China market can maintain double-digit growth in the long term.
  • Eternal Beauty’s financial performance would face challenges due to changes in consumer preferences, shifts in China’s domestic policies, international trade disputes, geopolitical conflicts, etc. Valuation could be lower than peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: New Fast Entry Rule for KOSPI 200 & KOSDAQ 150: Post-IPO Price Swings Ramping Up and more

By | Daily Briefs, ECM

In today’s briefing:

  • New Fast Entry Rule for KOSPI 200 & KOSDAQ 150: Post-IPO Price Swings Ramping Up
  • Via Technologies GDR Offering – US$212m GDR Offering Will Be Easily Digested
  • K Bank IPO: Valuation Insights
  • Tokyo Metro IPO – The Positives – Quasi-Monopoly Status
  • Upstream Bio IPO Preview: Severe Asthma/CRSwNP Program Advancing


New Fast Entry Rule for KOSPI 200 & KOSDAQ 150: Post-IPO Price Swings Ramping Up

By Sanghyun Park

  • Besides ranking in the top 50 by market cap, it must also meet a minimum float-adjusted cap for K200 fast entry: at least 50% of the 50th-ranked stock’s market cap.
  • Even if new stocks meet KRX’s float cap, their actual float share volume may still be low, risking inflation from local pension funds’ preemptive passive inflows post-listing.
  • This could reduce predictability for KOSPI 200 fast entry, increasing price swings post-listing and forcing traders to develop new volatility strategies after IPOs.

Via Technologies GDR Offering – US$212m GDR Offering Will Be Easily Digested

By Clarence Chu

  • Via Technologies (2388 TT) is looking to raise US$212m in its global depository receipts (GDRs) offering. Proceeds will be used to purchase overseas raw materials, and to replenish working capital.
  • Similar to previous GDR listings, the deal has had a long drawn out approval process. Thus, the deal is a very well flagged one.
  • The deal is a relatively small one to digest at 5.8 days of the stock’s three month ADV.

K Bank IPO: Valuation Insights

By Arun George

  • K Bank (279570 KS) is a Korean internet bank. It has launched an IPO to raise up to US$734 million.
  • We previously discussed the IPO in K Bank IPO: The Bear Case and K Bank IPO: The Bull Case.
  • We examine the syndicate’s valuation methodology. Our analysis suggests that K Bank is unattractively valued in the IPO price range. We would pass on the IPO.

Tokyo Metro IPO – The Positives – Quasi-Monopoly Status

By Sumeet Singh

  • Tokyo Metro (9023 JP)‘s  shareholders aim to raise up to US$2.3bn in its upcoming Japan IPO. 
  • Tokyo Metro (TKM) is one of the two metro network operators in the Tokyo region. It operates nine subway lines with a total of 180 stations.
  • In this note, we talk about the positive aspects of the deal.

Upstream Bio IPO Preview: Severe Asthma/CRSwNP Program Advancing

By Andrei Zakharov

  • Upstream Bio, a clinical-stage biotech company developing novel therapies for inflammatory and allergic diseases, filed for an IPO in the United States.
  • The biotech firm was backed by premier investors, including OrbiMed, Access Industries, Maruho Co., Samsara BioCapital, Omega Funds, and Enavate Sciences, among others.
  • I believe that company’s lead compound, verekitug (UPB-101), has a broader commercial opportunity than many investors appreciate.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Tokyo Metro (9023 JP) IPO: The Bull Case and more

By | Daily Briefs, ECM

In today’s briefing:

  • Tokyo Metro (9023 JP) IPO: The Bull Case
  • Sino-American Silicon GDR Offering – Relatively Large One to Digest, Although Discount Is Attractive
  • K Bank IPO – Peer Comparison – Lags Its Main Peer on Most Fronts


Tokyo Metro (9023 JP) IPO: The Bull Case

By Arun George

  • Tokyo Metro (TKYMETRO JP), a mass transit operator, is seeking to raise up to US$2.3 billion. Pricing is on 15 October, and the listing is on 23 October.   
  • Tokyo Metro is held 53.42% by the Minister of Finance and 46.58% by the Tokyo Metropolitan Government. 
  • The bull case rests on a core high-quality asset, future growth drivers, top-quartile profitability, high FCF generation, and peer-leading dividend payout. 

Sino-American Silicon GDR Offering – Relatively Large One to Digest, Although Discount Is Attractive

By Clarence Chu

  • Sino American Silicon Products (5483 TT) is looking to raise US$287m in its GDRs offering. Proceeds will be used to purchase overseas raw materials, repay bank loans and purchase machinery.
  • Similar to previous GDR listings, the deal has had a long drawn out approval process. Thus, the deal is a very well flagged one.
  • The deal is a relatively large one to digest at 15.7 days of the stock’s three month ADV.

K Bank IPO – Peer Comparison – Lags Its Main Peer on Most Fronts

By Sumeet Singh

  • K Bank (279570 KS) plans to raise up to US$740m in its upcoming South Korean IPO.
  • K Bank is one of three Internet-only banks in Korea. It provides a full range of commercial banking products and services.
  • In our previous note, we have looked at the company’s past performance. In this note, we will undertake a peer comparison.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: ECM Weekly (23rd Sep 2024) – Tokyo Metro and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (23rd Sep 2024) – Tokyo Metro, Midea, Intermestic, Sagility, Belstar, Kuaishou, Bajaj HF
  • Pre-IPO Zhejiang Taimei Medical Technology (PHIP Updates) – Some Points Worth the Attention
  • IREDA QIP Early Look – Strong Momentum, Although Valuations Are Eye-Popping


ECM Weekly (23rd Sep 2024) – Tokyo Metro, Midea, Intermestic, Sagility, Belstar, Kuaishou, Bajaj HF

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, Midea Group Co Ltd A (000333 CH) and Bajaj Housing Finance (BHF IN) hogged much of the limelight this week as well.
  • On the placements front, there were a few large US$400m+ placements across the region this week.

Pre-IPO Zhejiang Taimei Medical Technology (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Declining customer retention rate indicates that a slowdown in future revenue growth seems inevitable. If revenue growth stagnates, it means Taimei’s business model hasn’t been fully validated by the market.
  • Taimei’s IPO on SSE STAR Market was rejected. This means regulatory authorities don’t recognize Taimei’s core technology/performance prospects. Taimei has to take a step back and list on the HKEX.
  • Post-Investment valuation reached RMB8.1 billion after Series F financing. However, considering the continuous decline in valuation of its peers, we are concerned about Taimei’s future stock price performance after IPO.

IREDA QIP Early Look – Strong Momentum, Although Valuations Are Eye-Popping

By Clarence Chu

  • IREDA (1845911D IN) is looking to raise INR45bn (US$538m) via its qualified institutional placement (QIP).
  • Most recently on 19th Sept 2024, IREDA received the Department of Investment and Public Asset Management’s (DIPAM) approval for said QIP.
  • Overall, the deal wouldn’t be a large one for the stock to digest at just 4.7 days of three month ADV.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Ventive Hospitality Pre-IPO Tearsheet and more

By | Daily Briefs, ECM

In today’s briefing:

  • Ventive Hospitality Pre-IPO Tearsheet
  • K Bank IPO: The Bear Case


Ventive Hospitality Pre-IPO Tearsheet

By Nicholas Tan

  • Ventive Hospitality Ltd (0807075D IN) is looking to raise up to US$238m in its upcoming India IPO. The deal will be run by JMF, Axis, HSBC, ICICI, IIFL, Kotak, SBI.
  • Ventive is the largest hospitality asset owner amongst public listed market peers and is focused primarily on luxury offerings across business and leisure in India and Maldives.
  • All of its hospitality assets are operated or franchised by renowned global operators i.e. Marriott, Hilton, Minor and Atmosphere. 

K Bank IPO: The Bear Case

By Arun George

  • K Bank (279570 KS) is a Korean internet bank. It has launched an IPO to raise up to US$734 million.
  • In K Bank IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on rising competitive intensity, the smallest deposit base among Internet banks, below-peer loan book growth, and a high-risk crypto play due to the Dunamu partnership.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Ather Energy Pre-IPO Tearsheet and more

By | Daily Briefs, ECM

In today’s briefing:

  • Ather Energy Pre-IPO Tearsheet


Ather Energy Pre-IPO Tearsheet

By Akshat Shah

  • Ather Energy (1207922D IN) is looking to raise about US$536m in its upcoming India IPO. The deal will be run by HSBC, Nomura, JM Fin and Axis.
  • Ather is a pure play electric vehicle company in India designing and developing E2Ws, battery packs, charging infrastructure, associated software and accessories, also manufacturing battery packs and assembling E2Ws in-house.
  • According to CRISIL, Ather was the third largest player by volume of E2W sales in FY24.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Kuaishou Placement – US$480m Secondary Block Deal a Small One to Digest and more

By | Daily Briefs, ECM

In today’s briefing:

  • Kuaishou Placement – US$480m Secondary Block Deal a Small One to Digest
  • Hexaware Technologies Pre-IPO Tearsheet
  • Intermestic IPO: A Proven Business Model with Improving Financials
  • Intermestic IPO – Steady Domestic Business, but Limited International Exposure
  • BioAge Labs Launches IPO Roadshow, Seeks To Raise Up To $150M on the Nasdaq Exchange


Kuaishou Placement – US$480m Secondary Block Deal a Small One to Digest

By Clarence Chu

  • DCM Investments is looking to raise US$484m via selling its remaining stake in Kuaishou Technology (1024 HK).
  • While the current block deal isn’t entirely well flagged per se, it appears that DCM has since been trimming its stake on the open market.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Hexaware Technologies Pre-IPO Tearsheet

By Akshat Shah

  • Hexaware Technologies (HEXW IN)  is looking to raise about US$1.2bn in its upcoming India IPO. The deal will be run by JPM, Kotak, HSBC, IIFL Securities and Citi.
  • Hexaware Technologies is a global digital and technology services company delivering innovative solutions that help customers in their digital transformation journey and subsequent operations, as per the company.
  • Its offerings encompass five services, namely Design & Build, Secure & Run, Data & AI, Optimize, and Cloud Services.

Intermestic IPO: A Proven Business Model with Improving Financials

By Shifara Samsudeen, ACMA, CGMA

  • Japanese eyewear manufacturer and retailer, Intermestic (262A JP) has filed for an IPO on the Tokyo Stock Exchange and is planning to raise proceeds of $112m.
  • The company operates stores both domestically and internationally, and the company’s financials show strong improvement during the last few years.
  • Intermestic has not yet announced the terms for its IPO, and in this insight, we have discussed the company’s business models, outlook and financials.

Intermestic IPO – Steady Domestic Business, but Limited International Exposure

By Clarence Chu

  • Intermestic (262A JP) is looking to raise US$110m in its Japan IPO. Intermestic is an eyewear manufacturer of eyeglasses and eyeglass accessories in Japan.
  • Utilizing a specialty store retailer of private label apparel (SPA) model, the firm aims to provide a one-stop shop whereby manufacturing and retailing of its products are handled in-house.
  • In this note, we look at the firm’s past performance.

BioAge Labs Launches IPO Roadshow, Seeks To Raise Up To $150M on the Nasdaq Exchange

By Andrei Zakharov

  • BioAge Labs launches roadshow and sets terms for an IPO: a company offers 7.5M shares at the price range of $17.00-$19.00, implying a market cap of ~$580M at the midpoint.
  • Sofinnova Venture Partners plans to purchase ~$15M worth of BioAge Labs shares in this offering. The shares are expected to begin trading on Nasdaq on September 26, 2024.
  • I view IPO valuation (post-offering EV ~$280M and runway into 2028) as attractive and expect BioAge Labs shares will outperform during first trading day next week.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: K Bank IPO: The Bull Case and more

By | Daily Briefs, ECM

In today’s briefing:

  • K Bank IPO: The Bull Case
  • Belstar Microfinance Pre-IPO – Accelerating Profitability Growth With A Diversified Network
  • Mr. D.I.Y Holding (Thailand) Pre-IPO Tearsheet
  • Pre-IPO Carote Ltd (PHIP Updates) – High Performance Growth May Not Be Sustainable
  • Hive Box – Pre-IPO: To Understand Who Pays and Why They Pay
  • K Bank IPO – The Negatives – Ample Issues Along with Crypto Exposure & Lockup


K Bank IPO: The Bull Case

By Arun George

  • K Bank (279570 KS) is a Korean internet bank. It has launched an IPO to raise up to US$734 million. 
  • K Bank began operations in April 2017 as the first internet-only bank in Korea. KT Corp (030200 KS) and Woori Bank (000030 KS) are the two largest shareholders.
  • The bull case rests on rising market share, solid deposit growth, robust loan book growth, stable NIM, rising margins and a low NPL ratio.

Belstar Microfinance Pre-IPO – Accelerating Profitability Growth With A Diversified Network

By Akshat Shah

  • Belstar Microfinance Ltd (3624918Z IN) is looking to raise around US$156m in its upcoming India IPO.
  • Belstar Microfinance is a non-banking finance company (NBFC) in India with a focus on furnishing micro-enterprise loans. 
  • In this note, we talk about the company’s historical performance.

Mr. D.I.Y Holding (Thailand) Pre-IPO Tearsheet

By Nicholas Tan

  • Mr. DIY Holding (Thailand) (2472516D TB) (MRDIYT) is looking to raise as much as US$300m in its upcoming Thai IPO. The deal will be run by CIMB Thai Bank.
  • MRDIYT is the largest and fastest growing home improvement and general lifestyle retailer in Thailand, holding approximately 7.4% market share in 2023.
  • MRDIYT’s proposition is to offer competitive value for over 15,000 products across a variety of departments – hardware/tools, household appliances, electrical appliances, stationery, sporting goods, toys etc.

Pre-IPO Carote Ltd (PHIP Updates) – High Performance Growth May Not Be Sustainable

By Xinyao (Criss) Wang

  • Relying mainly on online channels and successful internationalization strategy, CAROTE’s performance growth showed strong momentum in recent years. However, after the short-term demand outbreak, future performance growth could slow down.
  • CAROTE adopts a product strategy similar to ZARA, launching a massive product matrix, constantly attracting consumers’ interest, but the innovation capability and core competitiveness of products are not high.
  • Valuation of CAROTE could be higher than Vesync (2148 HK).If Trump is elected, the friction/trade war between China and US may escalate, which is detrimental to CAROTE’s future valuation performance.

Hive Box – Pre-IPO: To Understand Who Pays and Why They Pay

By Ming Lu

  • Delivery workers would like to pay to save their time.
  • Retailers would also like to pay for return delivery to raise their service quality.
  • However, product buyers have to pay, but would not like to pay the delay fee.

K Bank IPO – The Negatives – Ample Issues Along with Crypto Exposure & Lockup

By Sumeet Singh

  • K Bank (279570 KS) plans to raise up to US$740m in its upcoming South Korean IPO.
  • K Bank is one of three Internet-only banks in Korea. It provides a full range of commercial banking products and services.
  • In this note, we talk about the not-so-positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Samvardhana Motherson QIP – Well Flagged US$780m QIP in a Decent Name and more

By | Daily Briefs, ECM

In today’s briefing:

  • Samvardhana Motherson QIP – Well Flagged US$780m QIP in a Decent Name
  • K Bank IPO Valuation Analysis
  • BioAge Labs IPO Preview: Investor Focus Has Turned To Azelaprag, A Huge Market Potential
  • K Bank IPO – The Positives – Fast Growth
  • Pre-IPO LinkChem Technology – The Business and the Concerns Behind


Samvardhana Motherson QIP – Well Flagged US$780m QIP in a Decent Name

By Clarence Chu

  • Samvardhana Motherson International Ltd (MOTHERSO IN) is looking to raise up to US$780m in its QIP. Together with the offering is a US$270m compulsory convertible debenture (CCD) offering.
  • The deal is very well flagged, having gone through rounds of board/shareholder approvals. The QIP has also been covered by domestic media reports.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

K Bank IPO Valuation Analysis

By Douglas Kim

  • Our base case valuation of K Bank is target price of 9,151 won per share, which is 4% lower than the low end of the IPO price range. 
  • Given the lack of upside in our target price relative to the IPO price range, we would avoid in subscribing to the IPO.
  • Our base case valuation is based on 1.6x P/B multiple using the company’s equity post IPO (2.35 trillion won). 

BioAge Labs IPO Preview: Investor Focus Has Turned To Azelaprag, A Huge Market Potential

By Andrei Zakharov

  • BioAge Labs, a clinical-stage biopharma company backed by a leading syndicate of biotech investors, filed to go public in the United States.
  • Anti aging and obesity biopharma startup is purely focused on chronic metabolic diseases and established partner agreements with Amgen and Eli Lilly.
  • I have a positive view of upcoming BioAge Labs IPO and expect a strong first-day return above the IPO offer price.

K Bank IPO – The Positives – Fast Growth

By Sumeet Singh

  • K Bank (279570 KS) plans to raise up to US$740m in its upcoming South Korean IPO.
  • K Bank is one of three Internet-only banks in Korea. It provides a full range of commercial banking products and services.
  • In this note, we talk about the positive aspects of the deal.

Pre-IPO LinkChem Technology – The Business and the Concerns Behind

By Xinyao (Criss) Wang

  • The sudden high growth in 2023 was benefited from the cooperation with related party Shandong LinkChem. Is the performance growth driven by LinkChem’s reliance on related party transactions sustainable?
  • LinkChem relies heavily on limited number of customers to contribute performance but the customer stability is not strong.Due to “low voice” in front of customers, cash flow is under pressure.
  • The barrier of terbium chloride product is not high and LinkChem will face fierce competition in the future, leading to decreasing YoY growth revenue. Valuation should be lower than peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars